Thursday, 18 October 2018

Alivira acquires Cadila’s animal health biz in Germany

25 April 2018 | News

Alivira Animal Health, through Alivira Ireland, has bought Bremer Pharma GmbH from Cadila for an enterprise value of 2.26 million euros.

Image credit- videoblocks.com

Image credit- videoblocks.com

Mumbai-based pharmaceutical company SeQuent Scientific's subsidiary Alivira Animal Health Ltd has acquired 100 per cent stake in Cadila Healthcare’s animal health business in Germany.

Alivira Animal Health, through Alivira Ireland, has bought Bremer Pharma GmbH from Cadila for an enterprise value of 2.26 million euros ($2.8 million).

Founded in 1982, Bremer Pharma is a veterinary health company in Germany which focuses on the cattle and swine segments. It has an injectable manufacturing facility.

This acquisition provides Alivira's with a beta-lactam & non-beta lactam injectables facility for EU markets, which compliments its Orals & Powders beta-lactam and non-beta lactam facility based at Barcelona in Spain. EU is Alivira's largest market accounting to 60 per cent of revenues.

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Click Here!




Survey Box

Can blockchain help cease fake drug distribution in India?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls